CNKI中胃癌新辅助治疗高被引文献计量分析

Quantitative Analysis of Highly Cited Literature on Neoadjuvant Treatment of Gastric Cancer in CNKI

摘要: 目的：分析我国胃癌新辅助治疗相关高被引文献的计量特征，把握胃癌新辅助治疗研究的发展趋势。方法：检索中国期刊全文数据库(CNKI) 2013~2023年的胃癌新辅助治疗相关文献，使用普赖斯定律来确定胃癌新辅助治疗的高被引文献，使用Excel 2021进行统计分析胃癌新辅助治疗文章中被引、年份、期刊、作者、单位、关键词、基金。结果：搜索出高被引文献有123篇，文献被引次数为7~78次，累计被引1766次，篇均被引14.30次；文献数目从2013年开始呈现波动上升至2017年达到峰值20篇，之后又呈现持续下降；文献分布在73种期刊，《实用癌症杂志》居于文献数、总被引频次第1位《中国肿瘤临床》局域篇均被引频次第1位；文献作者共429人、署名585次，总合作率91.87%，作者王韬、费建东、任彦先的署名数依次居前3位；作者机构114个，其中医院70个，占比61.40%，河北北方学院、武汉大学、复旦大学3个学校依次居署名文献数、折合文献数为前3位；相关关键词有190个、出现501次，“新辅助化疗”、“胃癌”、“进展期胃癌”、“奥沙利铂”、“胃肿瘤”的使用频次居前5位；123篇文献涉及基金的文献共56篇，占45.53%，累计73项次，篇均1.30项次。结论：通过分析近10年CNKI数据库胃癌新辅助治疗高被引文献，呈现出以《实用癌症杂志》《现代肿瘤医学》《中国肿瘤临床与康复》为代表的高被引期刊、以医院为核心发文机构、以胃癌新辅助治疗调查研究为主要对象、以省部级以上项目为主要资助基金的特征。但由于关键词的使用不够标准化，导致关键词之间交织反复，也是本次研究的一个缺陷。

Abstract: Objective: To analyze the quantitative characteristics of highly cited literature related to neoadjuvant treatment of gastric cancer in my country and grasp the development trend of neoadjuvant treatment research in gastric cancer. Methods: Search the Chinese Journal Full-text Database (CNKI) for literature related to neoadjuvant treatment of gastric cancer from 2013 to 2023, use Price’s law to determine the highly cited literature on neoadjuvant treatment of gastric cancer, and use Excel 2021 to perform statistical analysis of articles on neoadjuvant treatment of gastric cancer of citations, year, journal, author, unit, keywords, and funding. Results: 123 highly cited documents were found, and the number of citations ranged from 7 to 78, with a total of 1766 citations and an average of 14.30 citations. The number of documents began to fluctuate in 2013 and reached a peak of 20 in 2017. articles, and then continued to decline; the documents are distributed in 73 journals, “The Practical Journal of Cancer” ranks first in terms of number of documents and total citations, “Chinese Journal of Clinical Oncology” ranks first in local articles and citations; the authors of the documents have a total of 429 people, signed 585 times, with a total cooperation rate of 91.87%. The authors Wang Tao, Fei Jiandong, and Ren Yanxian ranked in the top three in terms of number of signatures; there are 114 author institutions, including 70 hospitals, accounting for 61.40%. Hebei Northern University, Wuhan University and Fudan University ranked in the top three in terms of number of signed documents and number of converted documents; there were 190 related keywords, appearing 501 times, including “neoadjuvant chemotherapy”, “gastric cancer”, “advanced gastric cancer”, “Olympic” “Thaliplatin” and “Gastric Tumor” were among the top 5 most frequently used; among the 123 documents, there were 56 documents involving funds, accounting for 45.53%, with a total of 73 entries, and an average of 1.30 entries. Conclusion: By analyzing the highly cited literature on neoadjuvant treatment of gastric cancer in the CNKI database in the past 10 years, the most highly cited journals represented by “The Practical Journal of Cancer”, “Journal of Modern Oncology”, “Chinese Journal of Clinical Oncology and Rehabilitation”, and hospitals It is the core issuing institution, takes investigation and research on neoadjuvant treatment of gastric cancer as the main object, and takes projects at the provincial and ministerial level as the main funding fund. However, because the use of keywords is not standardized enough, the keywords are intertwined and repeated, which is also a flaw of this study.